Gts Securities Llc
Source: SEC Form 13F · as of Mar 2026Gts Securities Llc holds 25 biotech & pharma companies tracked by BioSniper, totaling $7.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
25
Total value held
$7.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Teva Pharmaceutical Industries Limited (TEVA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| TEVATeva Pharmaceutical Industries Limited | 46,218 | $1.4M |
| GILDGILEAD SCIENCES, INC. | 7,077 | $986K |
| APLSApellis Pharmaceuticals, Inc. | 15,604 | $628K |
| REGNREGENERON PHARMACEUTICALS, INC. | 767 | $593K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,052 | $348K |
| INSMINSMED Inc | 1,991 | $326K |
| ABVXAbivax SA | 2,652 | $295K |
| BBIOBridgeBio Pharma, Inc. | 3,446 | $256K |
| PTGXProtagonist Therapeutics, Inc | 2,416 | $255K |
| TGTXTG THERAPEUTICS, INC. | 7,139 | $237K |
| BEAMBeam Therapeutics Inc. | 9,755 | $232K |
| INCYIncyte Corp. | 2,408 | $227K |
| PTCTPTC THERAPEUTICS, INC. | 3,212 | $219K |
| CYTKCYTOKINETICS INC | 3,206 | $211K |
| RLYBRallybio Corp | 22,016 | $197K |
| LSTALISATA THERAPEUTICS, INC. | 31,396 | $157K |
| NTLAIntellia Therapeutics, Inc. | 10,834 | $139K |
| IBRXImmunityBio, Inc. | 14,185 | $109K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 34,174 | $105K |
| PGENPRECIGEN, INC. | 26,764 | $104K |
| ADMAADMA BIOLOGICS, INC. | 10,153 | $91K |
| SLSSELLAS Life Sciences Group, Inc. | 10,329 | $44K |
| BRNSBarinthus Biotherapeutics plc. | 73,210 | $42K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 10,004 | $35K |
| GERNGERON CORP | 13,851 | $21K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.